Navigation Links
ADVENTRX Pharmaceuticals Provides Update on ANX-514
Date:2/15/2011

better represent the pharmacokinetics of docetaxel and are better predictors of clinical effects and outcomes.    

The FDA did not agree that evaluating bioequivalence using unbound docetaxel concentrations was warranted and determined that data from Study 514-01 was not adequate to conclude that the short period of higher exposure to total docetaxel concentrations observed early in the treatment cycle with ANX-514 do not adversely affect the safety or efficacy of ANX-514 relative to Taxotere.  

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary product candidates principally for the treatment of cancer.  More information can be found on the Company's web site at www.adventrx.com.  

Forward Looking Statements

ADVENTRX cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that are based on ADVENTRX's current expectations and assumptions. Such forward-looking statements include, but are not limited to, statements regarding the potential for submission and approval of an ANX-514 NDA by the FDA based on a single, additional clinical study, the continued development of ANX-514 by ADVENTRX, including additional clinical and manufacturing work, and ADVENTRX's ability to fund such activities, ADVENTRX's belief that the short period of higher exposure to total docetaxel concentrations observed early in the treatment cycle with ANX-514 in Study 514-01 does not adversely affect the safety or efficacy of ANX-514 relative to Taxotere, the regulatory approval and commercial launch of Exelbine by ADVENTRX, and the potential for pipeline expansion through acquisition of new product candidates or technologies, including consummation of ADVENTRX's acquisition of SynthRx, Inc. Actual
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc.
2. ADVENTRX to Provide Update Regarding Pipeline Expansion Efforts
3. ADVENTRX Pharmaceuticals to Present at the 13th Annual BIOCEO & Investor Conference on February 15
4. ADVENTRX Pharmaceuticals Receives PDUFA Date for Exelbine™ NDA
5. ADVENTRX Pharmaceuticals Announces Closing of $22.5 Million Financing
6. ADVENTRX Pharmaceuticals Announces Capital Raise of $22.5 Million
7. ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics
8. ADVENTRX Pharmaceuticals to Present at the 4TH Annual OneMedForum Business Development and Investment Conference on January 11
9. ADVENTRX Requests Meeting with FDA to Discuss ANX-514 Study
10. ADVENTRX Reports Third Quarter Financial Results
11. ADVENTRX to Present at the Wall Street Analyst Forum 21st Annual Institutional Investor Conference on November 11
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 23, 2014 Echo Therapeutics, Inc. ... company focused on skin permeation, continuous glucose monitoring ... W. Hollander has been appointed Chief Executive ... more than 20 years of experience in the ... most recently served as Vice President, Business Development, ...
(Date:12/24/2014)... , December 24, 2014 ... on Global Disposable Syringe Industry of 178 ... online business intelligence library. The ... Syringe Industry is a professional and deep ...  For overview analysis, the report introduces Disposable ...
(Date:12/24/2014)... Dec. 23, 2014  Lockton Dunning Benefits, the ... Companies, announced the addition of Vice President ... Lockton Dunning,s Pharmacy Consulting team, Excelsior Solutions. ... industry experience to the position.  Most recently, she ... at Diplomat Specialty Pharmacy, where she has held ...
Breaking Medicine Technology:Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5Kim Foerster Joins Lockton Companies 2
(Date:12/25/2014)... December 26, 2014 This is a ... the global Sterilizers industry with a focus on the ... market status of the Sterilizers manufacturers and is a ... individuals interested in the industry. This report provides a ... and manufacturing technology. In this part, the report presents ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 The report ... 2023” focuses on the current treatment landscape, unmet needs, ... market. TS-1 is an anti-cancer drug which is typically ... and is also used for treating gastric cancer and ... otastat potassium. The drug was first approved in 1999 ...
(Date:12/25/2014)... 2014 Recently, iFitDress.com, the popular online supplier ... announced its new selection of black one-shoulder cocktail dresses ... now; they are available at discounted prices, up to 70% ... will last for three weeks only. You know, we have ... are interested in our new items can visit our website ...
(Date:12/25/2014)... 25, 2014 Recently, BellasDress ... all its wedding dresses. BellasDress has chosen their best-selling ... gift choices for the holiday season. , Now, ... suitable wedding gowns here at discount prices. The business ... at its website. , “All our elegant ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 When head lice ... themselves in a frenzy to get rid of it while ... families in Coral Gables now have the solution right in ... salon clinic location, Lice Troopers provides full spectrum head lice ... Coral Gable area, including Sunset, Key Biscayne, Brickell, Coconut Grove, ...
Breaking Medicine News(10 mins):Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2
... ... the Parent Tested Parent Approved Seal by PTPA Media. PTPA Media (Parent Tested, Parent Approved) ... the quality of family life and worthy of a parent’s recommendation. , ... (PRWEB) July 1, 2010 -- The Good ...
... The Arizona Myeloma Network (AzMN) has presented a "Special Award" ... Translational Genomics Research Institute (TGen). The award recognizes TGen,s ... Hope for All Cancers, a 5K run-walk fundraising event, held ... presenting the award, AzMN President and Founder Barbara Kavanagh also ...
... NY) The Parkinson,s Disease Foundation (PDF) is pleased to ... to understand the cause(s) of and find a cure ... support the work of 15 leading scientists and are ... Grants and Research Fellowship Grants. The first program ...
... ... ... Beverly Hills Aesthetics, a leading Beverly Hills non-invasive cosmetic surgery center, today ... procedure, exclusive to Beverly Hills Aesthetics, combines Cellupulse with proprietary cutting edge technology developed ...
... ... of premium dietary supplements, announces the release of their new Alpha 3C™ formula, ... ... Purity Products®, a leading direct-to-consumer provider of premium dietary supplements, announces the release ...
... in the growth of prostate cancerthe most common cancer ... a suitable laboratory research model. Now researchers say they ... cancer initiation and progression. Their results were ... San Diego. "We hope this model will speed ...
Cached Medicine News:Health News:The Good Nite Lite Awarded the Parent Tested Parent Approved Seal 2Health News:Arizona Myeloma Network presents 'Special Award' to TGen president 2Health News:Parkinson's Disease Foundation announces research awards totaling $1.2 million 2Health News:Parkinson's Disease Foundation announces research awards totaling $1.2 million 3Health News:Beverly Hills Aesthetics Offers Revolutionary New Celluraze Procedure 2Health News:Beverly Hills Aesthetics Offers Revolutionary New Celluraze Procedure 3Health News:Purity Products Releases Alpha 3C 2Health News:New research model of human prostate cancer shows cancer development 2
... is a quiet, compact, efficient vacuum source ... oil-free design and TEFLON®/ETFE coated vapor path ... and reduced maintenance. Unique features include a ... and a 1-liter post-pump solvent recovery vessel ...
... two-stage, oil-sealed, rotary vane vacuum pumps specifically ... pump comes complete with a GBORK (Gas ... Mist Filter (EMF-10). The GBORK allows the ... keep the oil clean without losing oil. ...
... Thermo Savant offers several different two-stage, oil-sealed, ... standard freeze drying applications. Each pump comes ... Return Kit) and and Oil Mist Filter ... apply full gas ballast to keep the ...
... manifold for processing DirectPrep 96 plates ... plates ; Reduced sample handling and ... using DirectPrep 96 plates and MinElute ... Easy cleaning of internal components ...
Medicine Products: